Several studies have shown that miR-1915-3p modulates multidrug resistance, anti-apoptosis and stem cell differentiation by targeting BCL2 apoptosis regulator (BCL2) [17–19], prominin 1 (PROM1) and paired box 2 (PAX2) [20] in multiple types of cancers. Here, BCL2 is linked to cancer.